PMDA — authorised 27 September 2017
- Marketing authorisation holder: CSL Behring KK
- Status: approved
🇯🇵 Afstyla in Japan
PMDA authorised Afstyla on 27 September 2017
Marketing authorisation
Afstyla in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Japan
Frequently asked questions
Is Afstyla approved in Japan?
Yes. PMDA authorised it on 27 September 2017.
Who is the marketing authorisation holder for Afstyla in Japan?
CSL Behring KK holds the Japanese marketing authorisation.